Đang chuẩn bị liên kết để tải về tài liệu:
Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

While survival rates of extremely preterm infants have improved over the last decades, the incidence of neurodevelopmental disability (ND) in survivors remains high. | Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008

TÀI LIỆU LIÊN QUAN

Study of Subsidence detection by DinSAR and evaluation of some factors to the outcome

Early blood glucose profile and neurodevelopmental outcome at two years in neonatal hypoxic-ischaemic encephalopathy

Weak outcome predictors of multimodal rehabilitation at one-year follow-up in patients with chronic pain - a practice based evidence study from two SQRP centres

báo cáo hóa học: " Patient experiences with oily skin: The qualitative development of content for two new patient reported outcome questionnaires"

Báo cáo y học: "Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey"

Báo cáo y học: "Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases"

báo cáo khoa học: " Defining the effect and mediators of two knowledge translation strategies designed to alter knowledge, intent and clinical utilization of rehabilitation outcome measures: a study protocol [NCT00298727]"

Effects of initial graft tension on clinical outcome after anatomic double-bundle anterior cruciate ligament reconstruction: Comparison of two graft tension protocols

Radiological features do not predict failure of two-stage arthroplasty for prosthetic joint infection: A retrospective case–control study

Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: Study protocol for a multicenter open-label randomized phase II trial